Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist

The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that modulates gene expression following its binding and activation by structurally diverse chemicals. Species differences in AhR functionality have been observed, with the mouse AhR (mAhR) and human AhR (hAhR) exhibiting...

Full description

Bibliographic Details
Main Authors: Samantha C. Faber, Anatoly A. Soshilov, Sara Giani Tagliabue, Laura Bonati, Michael S. Denison
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:International Journal of Molecular Sciences
Subjects:
AhR
Online Access:http://www.mdpi.com/1422-0067/19/9/2692
id doaj-036cd3b1e1b546338192bbbb5c895fe9
record_format Article
spelling doaj-036cd3b1e1b546338192bbbb5c895fe92020-11-24T21:14:36ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-09-01199269210.3390/ijms19092692ijms19092692Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor AgonistSamantha C. Faber0Anatoly A. Soshilov1Sara Giani Tagliabue2Laura Bonati3Michael S. Denison4Department of Environmental Toxicology, University of California, Davis, CA 95616, USADepartment of Environmental Toxicology, University of California, Davis, CA 95616, USADepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milan 20126, ItalyDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milan 20126, ItalyDepartment of Environmental Toxicology, University of California, Davis, CA 95616, USAThe aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that modulates gene expression following its binding and activation by structurally diverse chemicals. Species differences in AhR functionality have been observed, with the mouse AhR (mAhR) and human AhR (hAhR) exhibiting significant differences in ligand binding, coactivator recruitment, gene expression and response. While the AhR agonist indirubin (IR) is a more potent activator of hAhR-dependent gene expression than the prototypical ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), it is a significantly less potent activator of the mAhR. DNA binding analysis confirmed the greater potency/efficacy of IR in stimulating transformation/DNA binding of the hAhR in vitro and domain-swapping experiments demonstrated that the enhanced response to IR was primarily due to the hAhR ligand binding domain (LBD). Site-directed mutagenesis and functional analysis studies revealed that mutation of H326 and A349 in the mAhR LBD to the corresponding residues in the hAhR LBD significantly increased the potency of IR. Since these mutations had no significant effect on ligand binding, these residues likely contribute to an enhanced efficiency of transformation/DNA binding by IR-bound hAhR. Molecular docking to mAhR LBD homology models further elucidated the different roles of the A375V mutation in TCDD and IR binding, as revealed by [3H]TCDD competitive binding results. These results demonstrate the differential binding of structurally diverse ligands within the LBD of a given AhR and confirm that amino acid differences within the LBD of AhRs contribute to significant species differences in ligand response.http://www.mdpi.com/1422-0067/19/9/2692Ah receptorAhRindirubinTCDDin vitroin silico
collection DOAJ
language English
format Article
sources DOAJ
author Samantha C. Faber
Anatoly A. Soshilov
Sara Giani Tagliabue
Laura Bonati
Michael S. Denison
spellingShingle Samantha C. Faber
Anatoly A. Soshilov
Sara Giani Tagliabue
Laura Bonati
Michael S. Denison
Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
International Journal of Molecular Sciences
Ah receptor
AhR
indirubin
TCDD
in vitro
in silico
author_facet Samantha C. Faber
Anatoly A. Soshilov
Sara Giani Tagliabue
Laura Bonati
Michael S. Denison
author_sort Samantha C. Faber
title Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
title_short Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
title_full Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
title_fullStr Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
title_full_unstemmed Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
title_sort comparative in vitro and in silico analysis of the selectivity of indirubin as a human ah receptor agonist
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2018-09-01
description The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that modulates gene expression following its binding and activation by structurally diverse chemicals. Species differences in AhR functionality have been observed, with the mouse AhR (mAhR) and human AhR (hAhR) exhibiting significant differences in ligand binding, coactivator recruitment, gene expression and response. While the AhR agonist indirubin (IR) is a more potent activator of hAhR-dependent gene expression than the prototypical ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), it is a significantly less potent activator of the mAhR. DNA binding analysis confirmed the greater potency/efficacy of IR in stimulating transformation/DNA binding of the hAhR in vitro and domain-swapping experiments demonstrated that the enhanced response to IR was primarily due to the hAhR ligand binding domain (LBD). Site-directed mutagenesis and functional analysis studies revealed that mutation of H326 and A349 in the mAhR LBD to the corresponding residues in the hAhR LBD significantly increased the potency of IR. Since these mutations had no significant effect on ligand binding, these residues likely contribute to an enhanced efficiency of transformation/DNA binding by IR-bound hAhR. Molecular docking to mAhR LBD homology models further elucidated the different roles of the A375V mutation in TCDD and IR binding, as revealed by [3H]TCDD competitive binding results. These results demonstrate the differential binding of structurally diverse ligands within the LBD of a given AhR and confirm that amino acid differences within the LBD of AhRs contribute to significant species differences in ligand response.
topic Ah receptor
AhR
indirubin
TCDD
in vitro
in silico
url http://www.mdpi.com/1422-0067/19/9/2692
work_keys_str_mv AT samanthacfaber comparativeinvitroandinsilicoanalysisoftheselectivityofindirubinasahumanahreceptoragonist
AT anatolyasoshilov comparativeinvitroandinsilicoanalysisoftheselectivityofindirubinasahumanahreceptoragonist
AT saragianitagliabue comparativeinvitroandinsilicoanalysisoftheselectivityofindirubinasahumanahreceptoragonist
AT laurabonati comparativeinvitroandinsilicoanalysisoftheselectivityofindirubinasahumanahreceptoragonist
AT michaelsdenison comparativeinvitroandinsilicoanalysisoftheselectivityofindirubinasahumanahreceptoragonist
_version_ 1716746577987502080